Vertex announces letter of intent with pan-Canadian Pharmaceutical Alliance for public reimbursement of CFTR modulators Extended to Include Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor)

17 September 2021 - Vertex Pharmaceuticals today announced that it has signed a letter of intent with the pan-Canadian Pharmaceutical ...

Read more →

A collaborative pilot on current awareness alerts for disinvestment and horizon scanning

31 August 2021 - In 2019, members of the Health Technology Assessment international Interest Group for Disinvestment and Early Awareness and ...

Read more →

Evrysdi (risdiplam) receives CADTH reimbursement recommendation for some patients with spinal muscular atrophy

30 August 2021 - Roche Canada today announced that the CADTH Canadian Drug Expert Committee has issued its final recommendation ...

Read more →

Cystic fibrosis patients, advocates urge Ontario government to provide ‘miracle drug’ funding

20 August 2021 - An Ontario teen living with Cystic Fibrosis and her mother are hoping to shine a light ...

Read more →

CADTH welcomes transfer of drug safety and effectiveness network

13 August 2021 - CADTH welcomes today’s announcement by the Canadian Institutes of Health Research and Health Canada that they ...

Read more →

Government of Canada negotiates additional agreement with Moderna for vaccine supply beyond 2021

13 August 2021 - The Government of Canada is committed to protecting the health and safety of Canadians by securing ...

Read more →

Halifax man devastated after insurer reverses decision to cover $25,000 cystic fibrosis drug

13 August 2021 - Stefan Strecko says he's pleaded with Canada Life to cover cost of 'miracle' drug. ...

Read more →

Canadian agency loses a battle in effort to force a drug maker to lower ‘excessive’ pricing

4 August 2021 - In a withering ruling, a Canadian appeals court overturned a controversial decision issued four years ago ...

Read more →

Court topples Canadian ruling that one of world's most expensive drugs is excessively priced

3 August 2021 - Soliris was originally approved to treat two blood disorders affecting about 180 Canadians, with the list price ...

Read more →

Frustrated cystic fibrosis patient speaks out after drug coverage denial

30 July 2021 - Twenty eight year old cystic fibrosis patient Stefan Strecko says he went from jubilation to devastation ...

Read more →

Advisory panel to develop a framework for a pan-Canadian prescription drug list

27 July 2021 - An Advisory Panel has been convened by CADTH to provide Health Canada with a recommended framework ...

Read more →

Dupixent (dupilumab injection) receives positive recommendation from CADTH and INESSS for the treatment of severe asthma

22 July 2021 - Recommendation supported by multiple clinical trials that demonstrated a reduced frequency of asthma exacerbations compared to placebo, ...

Read more →

Cystic fibrosis patients upset over recommended restrictive criteria for life saving drug

15 July 2021 - 'By narrowly defining accessibility and continuation criteria CADTH’s recommendation overlooks many of Trikafta’s significant benefits,' says chief ...

Read more →

'A price on your life': Toronto cystic fibrosis patients slam review process while waiting for access to life-saving treatment

13 July 2021 - While Health Canada approved Trikafta for patient use on June 18, 2021, it is still not ...

Read more →

Canada again delays overhaul to patented medicine pricing system

29 June 2021 - Health Minister Patty Hajdu is delaying the first big overhaul of Canada’s patented medicines pricing system ...

Read more →